![Dan Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Dan Liu is a Member-Supervisory Board at HitGen, Inc. He previously served as a Non-Executive Director at Wuhan YZY Biopharma Co., Ltd. Dr. Liu holds a doctorate degree from Vanderbilt University and Yale University, and an undergraduate degree from Nanjing University.
Eerdere bekende functies van Dan Liu
| Bedrijven | Functie | Einde |
|---|---|---|
| HITGEN INC. | Directeur/Bestuurslid | 28-06-2024 |
| WUHAN YZY BIOPHARMA CO., LTD. | Directeur/Bestuurslid | 30-04-2024 |
Opleiding van Dan Liu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
95
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
 Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HitGen, Inc.
 HitGen, Inc. BiotechnologyHealth Technology Develops innovative drugs | Health Technology |
Wuhan YZY Biopharma Co., Ltd.
 Wuhan YZY Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and commercializes immune-oncology therapies | Health Technology |
